ANIKA THERAPEUTICS, INC.

Analyst Reco. Anika Therapeutics, Inc.

Equities

ANIK

US0352551081

Market Closed - Nasdaq Other stock markets 21:00:00 28/06/2024 BST			5-day change	1st Jan Change
25.33 ^USD	-1.52%		-2.58%	+11.78%

05-30	Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics	CI
05-28	Anika Therapeutics Approves $40 Million Share Repurchase Program	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating	03-14	MT
Barrington Ups Price Target on Anika Therapeutics to $29 From $28, Reiterates Outperform Rating	01-04	MT
Barrington Ups PT on Anika Therapeutics to $28 From $24, Expecting JPR Business to Produce 'Double-digit, Top-line Growth', Maintains Outperform Rating	11-03	MT
Barrington Upgrades Anika Therapeutics to Outperform From Market Perform, Saying 'Downdraft in Shares Seems Materially Overdone,' Price Target is $24	14/08/23	MT
Stephens Adjusts Price Target on Anika Therapeutics to $23 From $28, Maintains Equal-Weight Rating	10/08/23	MT
Barrington Research Downgrades Anika Therapeutics to Market Perform From Outperform After Full-Year 2023 Forecast Below Expectations	07/03/23	MT
Barrington Research Downgrades Anika Therapeutics to Market Perform From Outperform	07/03/23	MT
Barrington Upgrades Anika Therapeutics to Outperform From Market Perform, Price Target is $31	09/11/22	MT
Stephens Reinstates Anika Therapeutics at Equalweight With $26 Price Target	14/10/22	MT
Stephens Downgrades Anika Therapeutics to Equalweight from Overweight, Adjusts Price Target to $35 from $50	09/03/22	MT
Stephens Starts Anika Therapeutics at Overweight With $55 Price Target	16/11/21	MT
Barrington Adjusts Price Target on Anika Therapeutics to $48 From $44, Keeps Outperform Rating	05/11/21	MT
ANIKA THERAPEUTICS : UBS Starts Anika Therapeutics at Neutral With $46 Price Target	16/07/21	MT
ANIKA THERAPEUTICS : Barrington Research Upgrades Anika Therapeutics to Outperform From Market Perform; Price Target is $43	16/12/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer